Over 7,500 medications in stock!
100% Original medicines of Russian and world brands
Fast international shipping and delivery!
Free shipping order $150
24/7 Customer support

CO-VAMLOSET™ tablets 5mg+160mg+12.5mg, 90pcs

🔥 6 items sold in last 3 hours
4 people are viewing this product
Active Ingredient:

, ,

Manufacturer:

$118.0

or
Buy from 5 to 10 items and get 2% OFF
on each product
Buy from 11 to 30 items and get 5% OFF
on each product
Buy from 31 to 100 items and get 10% OFF
on each product
Buy from 101 to ∞ items and get 15% OFF
on each product

All forms of

CO-VAMLOSET™ tablets 10mg+160mg+12.5mg, 30pcs

$61.0
Add to cart

CO-VAMLOSET™ tablets 10mg+160mg+12.5mg, 90pcs

$129.5
Add to cart

Analogs of CO-VAMLOSET™

AMLODIPINE+VALSARTAN tablets 5mg+160mg, 90pcs

$69.0
Add to cart

AMLODIPINE+VALSARTAN tablets 5mg+80mg, 30pcs

$29.0
Add to cart

AMLODIPINE+VALSARTAN tablets 5mg+80mg, 90pcs

$58.5
Add to cart

AMLODIPINE tablets 10mg, 120pcs

$20.0
Add to cart

Table of Contents

CO-VAMLOSET™ 5mg+160mg+12.5mg 90 Tablets Pack Buy Online

CO-VAMLOSET Tablets: A Comprehensive Overview

Managing high blood pressure effectively is crucial for long-term cardiovascular health. CO-VAMLOSET tablets offer a combined approach to hypertension management, utilizing a triple-combination therapy to achieve optimal blood pressure control.

This comprehensive overview delves into the key aspects of CO-VAMLOSET, a medication designed to address the complexities of hypertension. Understanding its mechanism of action, potential benefits, and risks is vital for both patients and healthcare professionals.

Understanding CO-VAMLOSET

CO-VAMLOSET is a triple-combination medication used in the management of hypertension. It uniquely combines three active ingredients: amlodipine, a calcium channel blocker; valsartan, an angiotensin II receptor antagonist; and hydrochlorothiazide, a thiazide diuretic. This synergistic blend addresses hypertension through multiple mechanisms, offering a potentially more effective approach than single-agent therapy for some patients.

Amlodipine relaxes blood vessels, reducing vascular resistance and lowering blood pressure. Valsartan blocks the effects of angiotensin II, a hormone that constricts blood vessels. Hydrochlorothiazide increases the excretion of sodium and water from the body, reducing blood volume and subsequently blood pressure. The combined action of these three components provides a comprehensive approach to blood pressure control, making it a suitable option for individuals whose hypertension is not adequately managed by single-agent treatments.

The precise formulation of CO-VAMLOSET, with its specific dosages of each component, is carefully designed to optimize the therapeutic effect while minimizing potential side effects. Individual responses to medication vary, and the effectiveness of CO-VAMLOSET will depend on factors such as the severity of hypertension, the patient’s overall health, and other medications being taken. Always consult a healthcare professional before starting or changing any medication regimen.

Mechanism of Action

CO-VAMLOSET’s effectiveness stems from the combined actions of its three active components, each targeting a different aspect of blood pressure regulation. Amlodipine, a calcium channel blocker, works by relaxing the blood vessels, allowing blood to flow more easily and reducing the pressure on artery walls. This vasodilation is a key mechanism in lowering blood pressure.

Simultaneously, valsartan, an angiotensin II receptor blocker (ARB), inhibits the effects of angiotensin II, a hormone that causes blood vessels to narrow. By blocking angiotensin II’s action, valsartan further promotes vasodilation and reduces blood pressure. This dual approach, combining vasodilation from two different pathways, is a significant advantage.

Finally, hydrochlorothiazide, a thiazide diuretic, increases the excretion of sodium and water from the body. This reduction in blood volume contributes to lower blood pressure. The combined effect of these three mechanisms—vasodilation via two distinct pathways and reduced blood volume—results in a more comprehensive and effective reduction in blood pressure than any single agent could provide alone. This synergistic effect is a cornerstone of CO-VAMLOSET’s therapeutic profile.

Dosage and Administration

The recommended dosage of CO-VAMLOSET is typically one tablet per day, taken orally. This should be administered at the same time each day, usually in the morning, to maintain consistent blood pressure control. It’s crucial to swallow the tablet whole; crushing or chewing the tablet can alter the drug’s release and effectiveness, potentially leading to unpredictable results.

The specific dosage of CO-VAMLOSET (5mg amlodipine, 160mg valsartan, and 12.5mg hydrochlorothiazide) is determined by a healthcare professional based on individual patient needs and response to therapy. Adjustments to the dosage may be necessary depending on blood pressure readings and overall health. It is vital to follow the prescribed dosage and not alter it without consulting with a physician.

Patients should be aware that it may take several weeks for CO-VAMLOSET to reach its full therapeutic effect. Regular monitoring of blood pressure is essential to assess the medication’s effectiveness and make any necessary adjustments. It’s also crucial to report any side effects to a healthcare provider immediately. Consistent adherence to the prescribed dosage and schedule is paramount for optimal treatment outcomes. Never adjust the dosage independently; always consult a doctor for any changes.

Potential Benefits

CO-VAMLOSET offers several potential benefits for patients with hypertension. The primary advantage lies in its ability to effectively lower blood pressure, reducing the risk of serious cardiovascular complications such as heart attack, stroke, and kidney disease. This is achieved through the synergistic action of its three active ingredients, targeting multiple pathways involved in blood pressure regulation.

For patients whose hypertension is not adequately controlled by single-agent therapies, CO-VAMLOSET may provide superior blood pressure control. The combined approach may lead to improved overall cardiovascular health and a better quality of life. This is especially relevant for individuals with more severe hypertension or those who haven’t achieved satisfactory results with other treatments.

The convenience of a single daily dose simplifies the medication regimen, enhancing patient adherence. This streamlined approach to treatment can significantly contribute to long-term blood pressure management. However, individual responses to medication vary, and the actual benefits experienced will depend on several factors, including the severity of the condition, overall health, and other medications a patient may be taking. Always discuss potential benefits with your healthcare provider.

Pros

  • Effective Blood Pressure Reduction: CO-VAMLOSET’s triple-combination approach can lead to significant reductions in blood pressure, potentially exceeding the effectiveness of single-agent therapies for some individuals. This comprehensive approach targets multiple aspects of blood pressure regulation.
  • Reduced Cardiovascular Risk: By effectively lowering blood pressure, CO-VAMLOSET helps reduce the risk of serious cardiovascular events like heart attacks, strokes, and kidney disease. This benefit is a direct consequence of improved blood pressure control.
  • Convenient Single-Daily Dose: The once-daily dosing regimen simplifies treatment adherence, making it easier for patients to maintain consistent medication intake. This simplicity can significantly improve long-term treatment success.
  • Synergistic Action: The combined action of amlodipine, valsartan, and hydrochlorothiazide offers a synergistic effect, meaning their combined impact is greater than the sum of their individual effects. This combined action is a key factor in CO-VAMLOSET’s effectiveness.

Potential Risks

While CO-VAMLOSET offers significant benefits in managing hypertension, it’s crucial to be aware of potential risks and side effects. Like all medications, CO-VAMLOSET can cause adverse reactions, although not everyone experiences them. The frequency and severity of these side effects vary greatly among individuals. Close monitoring and communication with your healthcare provider are essential.

Some common side effects associated with CO-VAMLOSET’s components include dizziness, headache, fatigue, and swelling in the ankles or feet. More serious, though less common, side effects can include a persistent dry cough, changes in kidney function, and an increased risk of low blood pressure, especially when initially starting the medication or after a dose increase. These serious side effects necessitate immediate medical attention.

Certain individuals may be at a higher risk of experiencing adverse reactions. This includes people with pre-existing conditions such as kidney disease, liver disease, or heart failure. Before starting CO-VAMLOSET, it’s imperative to discuss your complete medical history and any other medications you are taking with your doctor to assess the risks and benefits. Open communication with your healthcare provider is essential for safe and effective treatment.

Cons

  • Potential Side Effects: CO-VAMLOSET, like other medications, carries the risk of side effects. These can range from mild (dizziness, headache) to more serious (cough, kidney problems, low blood pressure). The likelihood and severity of side effects vary significantly between individuals. Careful monitoring is crucial.
  • Drug Interactions: CO-VAMLOSET may interact with other medications, potentially reducing their effectiveness or increasing the risk of side effects. It’s essential to inform your doctor about all medications, supplements, and herbal remedies you are taking.
  • Contraindications: CO-VAMLOSET is not suitable for everyone. Pre-existing conditions such as severe kidney or liver problems, certain heart conditions, or allergies to its components can make it unsafe. A thorough medical evaluation is necessary before starting treatment.
  • Gradual Onset of Effect: The full therapeutic effect of CO-VAMLOSET may not be immediately apparent, requiring several weeks for optimal blood pressure control. Regular monitoring and patience are important during the initial phase of treatment.

Important Considerations

Before starting CO-VAMLOSET, or any new medication, it is crucial to have a comprehensive discussion with your doctor. This conversation should cover your complete medical history, including any pre-existing conditions, allergies, and other medications you’re currently taking. This information is vital for determining the appropriateness and safety of CO-VAMLOSET for your individual circumstances.

Regular monitoring of your blood pressure is essential while taking CO-VAMLOSET. This allows your doctor to assess the medication’s effectiveness and make necessary adjustments to the dosage or treatment plan. Regular check-ups are integral to ensuring safe and effective management of your hypertension.

Inform your doctor immediately about any new or worsening symptoms while taking CO-VAMLOSET. These symptoms could indicate side effects or interactions with other medications. Prompt reporting allows for timely intervention and minimizes potential risks. Open communication with your healthcare provider is critical for optimal outcomes and safety.

Contraindications and Precautions

CO-VAMLOSET is contraindicated in individuals with known hypersensitivity to amlodipine, valsartan, hydrochlorothiazide, or any other components of the formulation. Patients with a history of angioedema related to ACE inhibitors or ARBs should also avoid CO-VAMLOSET due to the risk of similar reactions. This precaution is critical for patient safety.

Caution is advised in patients with impaired renal function, as CO-VAMLOSET can affect kidney function. Regular monitoring of kidney function is necessary during treatment. Similarly, individuals with hepatic impairment should use CO-VAMLOSET with caution, as the medication may impact liver function. Close monitoring is crucial in both cases.

Pregnancy and breastfeeding are contraindications for CO-VAMLOSET. The medication should be discontinued if pregnancy is planned or suspected. Women of childbearing age should use appropriate contraception during treatment. The potential risks to the developing fetus or nursing infant outweigh any potential benefits of the medication. Alternative treatment options should be considered in these cases.

Conclusion

CO-VAMLOSET represents a significant advancement in the treatment of hypertension, offering a triple-combination approach to blood pressure management. Its unique formulation, combining amlodipine, valsartan, and hydrochlorothiazide, provides a synergistic effect, potentially leading to superior blood pressure control compared to single-agent therapies for many patients. This can translate to improved cardiovascular health and a better quality of life.

However, the potential benefits must be carefully weighed against potential risks and side effects. Individual responses to medication vary, and close monitoring by a healthcare professional is crucial to ensure safe and effective treatment. Regular blood pressure checks, open communication with your doctor about any symptoms, and adherence to the prescribed dosage are paramount for optimal outcomes.

Ultimately, the decision to use CO-VAMLOSET should be made in consultation with a healthcare provider. They can assess your individual needs and risk factors to determine if this medication is the appropriate choice for you. Remember, effective management of hypertension requires a comprehensive approach that includes lifestyle modifications alongside medication, when necessary. This holistic strategy is key to long-term cardiovascular health.

  • Co-Vamloset™ Tablets 5Mg+160Mg+12.5Mg, 90Pcs Buy Online 2
    [Author]

    Georgia Austin is a seasoned SEO content writer, editor, and content marketing strategist with over 7 years of experience crafting compelling copy for leading brands in the healthcare and pharmaceutic...

    View all posts
  • Co-Vamloset™ Tablets 5Mg+160Mg+12.5Mg, 90Pcs Buy Online 4
    [Editor]

    Jonathan Brown is a seasoned professional editor, researcher, and educator with over 12 years of experience helping authors find their voice and polish their writing. As a content editor for RxPulsar....

    View all posts
  • Co-Vamloset™ Tablets 5Mg+160Mg+12.5Mg, 90Pcs Buy Online 6
    [Medical reviewer]

    Dr. Elizabeth Dennis is a highly skilled Orthopedic Surgeon and consultant for RxPulsar.com, a licensed online pharmacy. She specializes in the management and surgical treatment of knee, shoulder, and...

    View all posts

Reviews

There are no reviews yet.

Be the first to review “CO-VAMLOSET™ tablets 5mg+160mg+12.5mg, 90pcs”

Your email address will not be published. Required fields are marked

Similar products

ARIFAM™ modified-release tablets 10mg+1.5mg, 30pcs

$57.0
Add to cart

APROVASK™ tablets 10mg+150mg, 28pcs

$73.0
Add to cart

APROVASK™ tablets 10mg+300mg, 28pcs

$102.0
Add to cart

APROVASK™ tablets 10mg+300mg, 56pcs

$174.5
Add to cart

ANGIAKAND™ tablets 16mg, 28pcs

$57.0
Add to cart

ANGIAKAND™ tablets 8mg, 28pcs

$52.0
Add to cart

ANAPRILIN™ RENEVAL™ tablets 10mg, 112pcs

$9.5
Add to cart

ANAPRILIN™ RENEVAL™ tablets 40mg, 112pcs

$15.0
Add to cart

AMPRILAN™ tablets 1.25mg, 30pcs

$8.0
Add to cart

AMPRILAN™ tablets 10mg, 30pcs

$17.5
Add to cart

AMPRILAN™ tablets 10mg, 90pcs

$46.5
Add to cart

AMPRILAN™ tablets 5mg, 30pcs

$9.5
Add to cart

AMLODIPINE-VERTEX™ tablets 5mg, 30pcs

$9.5
Add to cart

AMLODIPINE+LISINOPRIL tablets 10mg+20mg, 30pcs

$38.5
Add to cart

AMLODIPINE+LISINOPRIL tablets 5mg+10mg, 30pcs

$36.0
Add to cart

AMLODIPINE+PERINDOPRIL-SZ™ tablets 5mg+4mg, 30pcs

$24.0
Add to cart

AMLODIPINE-AKOS™ tablets 10mg, 30pcs

$13.5
Add to cart

AMLODIPINE tablets 10mg, 30pcs

$9.5
Add to cart

AMLODIPINE tablets 5mg, 30pcs

$8.0
Add to cart

AMLODIPINE tablets 5mg, 90pcs

$13.5
Add to cart

AMLODIPINE+VALSARTAN tablets 10mg+160mg, 30pcs

$40.0
Add to cart

AMLODIPINE+VALSARTAN tablets 5mg+160mg, 90pcs

$69.0
Add to cart

AMLODIPINE+VALSARTAN tablets 5mg+80mg, 30pcs

$29.0
Add to cart

AMLODIPINE+VALSARTAN tablets 5mg+80mg, 90pcs

$58.5
Add to cart
Select your currency